Targeting malignant B cells of lymphoma and leukemia with genetically engineered T-cell clones.
Jensen
M C
MC
Beckman Research Institute, Division of Molecular Medicine, City of Hope National Medical Center, Duarte, CA 91010-3000, USA.
D000818:Animals; D001402:B-Lymphocytes / Q000737:chemistry* / Q000276:immunology*; D002478:Cells, Cultured; D018014:Gene Transfer Techniques; D019337:Hematologic Neoplasms / Q000276:immunology / Q000628:therapy; D006801:Humans; D007938:Leukemia / Q000276:immunology / Q000628:therapy*; D008223:Lymphoma / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000378:metabolism